A Surgeon in London Removed a Man's Prostate From 1,500 Miles Away
Dr. Dereck Mush, MD, MBA
Vitestro
Autonomous blood drawing robot combining AI, ultrasound guidance and automated needle placement.
What they do
Vitestro's Aletta device received FDA De Novo authorization on August 19, 2026 (DEN250046), the first autonomous robotic phlebotomy device authorized in the United States. The company raised $70M in March 2026.
The record
- Vertical
- Devices & Robotics
- Sub-segment
- Robotic phlebotomy
- Product type
- Medical device
- Stage
- Series B
- Headquarters
- Utrecht, Netherlands
- Region
- Europe
- Founded
- Not disclosed
- Total funding
- $70M raised
Notable investors: Labcorp Venture Fund, Mayo Clinic, Sutter Health, Fred Moll.
Also in Devices & Robotics
Related on The Signal
Dr. Dereck Mush, MD, MBA
Two Years Into His Neuralink Implant, the First Patient Is Playing Chess With His Mind
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
The 8 Most Innovative MedTech Devices Right Now
From a pacemaker the size of a vitamin to a scanner that books its own follow-up, these are the devices actually changing care in 2026.
Dr. Dereck Mush, MD, MBA
Surgical Robotics After the Monopoly: What Changes When the Patents Expire
Dr. Dereck Mush, MD, MBA